The global diabetic socks market is estimated to be worth USD 185.18 million by 2029 from USD 144.27 million in 2024, growing at a CAGR of 5.12% from 2024 to 2029.
They're important to diabetic foot care because high blood sugar levels can harm the nervous and circulatory systems. Diabetic neuropathy reduces sensation in the feet, especially the soles, and increases the risk of injury. It can also make a diabetic person oblivious to an injury, causing treatment to be delayed.
Smart socks are the most recent innovation in diabetic socks. Smart socks use fiber optic sensors to monitor pressure, humidity, and foot joints and ankles to detect the onset of ulcers in areas where nerve loss has occurred. Amputations and deaths due to foot ulcers and infections can be dramatically reduced using smart diabetic socks. Consumer perceptions of diabetic socks are changing because of the vast range of illness consequences associated with diabetes. Diabetic socks are now seen as more than merely therapeutic clothing but also as a modern medical accessory.
Diabetic socks are gaining popularity due to their preventive and non-invasive capabilities as major manufacturers compete for therapeutic accessories. The growing prevalence of diabetes worldwide is majorly propelling the growth of the diabetic socks market. Therefore, technological advances and improvements would drive innovation in the characteristics of diabetic socks, generating substantial potential for market players in the healthcare industry and the textile industry. According to the IDF Diabetes Atlas, around 463.0 million persons aged 20 to 79 suffer from diabetes globally, with the majority (79.4%) living in low- and middle-income countries. Diabetes is expected to affect 578.4 million individuals by 2030, with a total of 700.2 million adults suffering from the disease by 2045. Furthermore, the prevalence of type 1 diabetes in children under the age of 15 has been continuously rising. Annual growth is expected to be around 3%, with strong evidence of regional variances. Type 1 diabetes affects about a million children under the age of 20. There are around 4.2 million adults aged 20 to 79 in the United States.
One of the major factors driving the market growth is the rising number of diabetic neuropathy cases around the world. The diabetic socks market is expected to rise further due to the increased popularity of diabetic socks due to their safe and non-invasive properties. The cost efficiency of diabetic socks and increasing health awareness in the millennial population boost the market growth. In the coming years, technological developments and a preference for non-invasive treatment will create more possibilities for the diabetic socks market to grow. The rise in the cost of diabetic socks, on the other hand, is expected to hinder the diabetic socks market's expansion over the forecast period.
The lack of public awareness of diabetes socks could pose an additional hurdle to the diabetic socks market's growth soon. Local manufacturers are becoming threats to well-established brands as they are selling products at a cheaper rate. Rather than investing in prevention, diabetic patients make investments to directly cure the condition, which hinders market growth.
The COVID-19 pandemic has largely affected almost every industry. They face problems like manufacturing disruption due to a lack of raw materials and lack of labour force and supply chain management has collapsed due to government regulations and lockdowns. Its long-term impacts are expected to have an influence on industry growth during the forecast period.
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 to 2029 |
|
Base Year |
2023 |
|
Forecast Period |
2024 to 2029 |
|
CAGR |
5.12% |
|
Segments Covered |
By Product Type, Material, Distribution Channel, and Region |
|
Various Analyses Covered |
Global, Regional, and country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
3M, BSN Medical, SIGAVARIS, Syounaa, DJO, LLC., Siren Care, Hangzhou Aidu Trading Co., Ltd, Cupron, SIMCAN, Soyad Brothers LLC and PediFix Inc. |
Factors such as higher diabetic patient preference, comprehensive foot coverage, and therapeutic benefits are propelling the growth of the knee length segment in the global market. Countries such as the United States, China, and Germany have higher awareness of knee-length diabetic socks, hence, the demand for these socks in these countries is high compared to the other countries, which is a favorable factor in the growth rate of the knee length segment in the global market.
The calf-length segment is anticipated to register the fastest CAGR in the global market during the forecast period. Because the calf length provides better leg covering and optimal comfort and support, it is often used. An increase in the number of diabetic patients seeking a balance between coverage and comfort, versatility, suitable for various footwear styles, and therapeutic benefits are driving the growth of the calf length segment in the global market.
Based on material, the cotton segment held 40.7% of the global market share in 2023 and the domination of the cotton segment is expected to continue throughout the forecast period owing to the multiple advantages of cotton socks, such as being lightweight, easy to clean, and breathable over other materials.
The convenience of one-stop shopping, product visibility, and accessibility are contributing to the growth of the hypermarket segment in the global market. The e-commerce segment is a promising distribution channel in the global market and is expected to register a CAGR of 6% during the forecast period. Increased internet penetration, particularly in North America, Europe, and Asia-Pacific, along with a diverse network of e-commerce firms, will lead to online channels gaining market share in the forecast period. Consumer preference is increasing toward products from offline businesses such as pharmacies and drug stores, and hypermarkets.
The domination of the North American region in the global market is likely to continue throughout the forecast period. The growing prevalence of diabetes and related foot complications and rising awareness about diabetic care and preventive measures are majorly propelling the growth of the diabetic socks market in North America. Technological advancements in sock materials to provide enhanced comfort is further fuelling the growth rate of the North American market. The U.S. had 68.7% of the North American market share in 2023 and is expected to grow at a CAGR of 6.4% during the forecast period.
The growth of the European market is primarily attributed to the increasing patient population of type 1 diabetes, the growing aging population who are prone to diabetes, rising focus on preventative foot care among diabetic patients, and an increasing number of initiatives from the governments of European countries around diabetes management. Germany and the UK played a big role in the European market in 2023 and captured around half of the European market share.
The Asian market is expected to grow at the fastest CAGR among all the regions in the global market during the forecast period due to the increasing number of diabetes patients in Asian countries and the increasing population in countries like India and China. According to a report by the International Diabetes Federation, diabetes cases in China are recorded as around 117 million, and 77 million cases in India. The rapidly growing diabetic patient population in China and India and rising demand for diabetic socks as a preventive healthcare measure are propelling the growth of the diabetic socks market in the Asia-Pacific region. China occupied 40.9% of the APAC market share in 2023 and stood as the leader in the APAC region and the domination of China in the APAC region is likely to continue throughout the forecast period.
The growing disposable income and increasing awareness of diabetes management among diabetics in Latin America are driving the growth of the Latin American market. Brazil is the major player in the Latin American market. The MEA region is estimated to account for a moderate share of the global market during the forecast period.
3M, BSN Medical, SIGAVARIS, Syounaa, DJO, LLC., Siren Care, Hangzhou Aidu Trading Co., Ltd., Cupron, SIMCAN, Soyad Brothers LLC and PediFix Inc. are some of the notable players in the global diabetic socks market. The actions of a few important companies in this market determine the competitive dynamics, and their strategies are aiding the expansion of the ambulatory arrhythmia monitoring devices market. These companies are concentrating on creating and deploying monitoring systems that incorporate smart technology to improve the efficiency and accuracy of cardiac monitoring.
By Product Type
Ankle Length
By Material
By Distribution Channel
By Region
Frequently Asked Questions
The global diabetic socks market was worth USD 130.56 million in 2022.
The diabetic socks market is driven by factors such as the increasing prevalence of diabetes, growing awareness about foot care among diabetic patients, and advancements in sock technology catering to diabetic needs.
Technological advancements contribute to the development of innovative diabetic sock solutions, including smart socks with monitoring capabilities, temperature control features, and materials that enhance overall foot health.
Companies playing a leading role in the global market are 3M, BSN Medical, SIGAVARIS, Syounaa, DJO, LLC., Siren Care, Hangzhou Aidu Trading Co., Ltd., Cupron, SIMCAN, Soyad Brothers LLC and PediFix Inc.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region